BR112014006559A2 - derivados do ácido betulínico com atividade antiviral - Google Patents

derivados do ácido betulínico com atividade antiviral

Info

Publication number
BR112014006559A2
BR112014006559A2 BR112014006559A BR112014006559A BR112014006559A2 BR 112014006559 A2 BR112014006559 A2 BR 112014006559A2 BR 112014006559 A BR112014006559 A BR 112014006559A BR 112014006559 A BR112014006559 A BR 112014006559A BR 112014006559 A2 BR112014006559 A2 BR 112014006559A2
Authority
BR
Brazil
Prior art keywords
antiviral activity
acid derivatives
betulinic acid
compounds
formula
Prior art date
Application number
BR112014006559A
Other languages
English (en)
Portuguese (pt)
Inventor
Regueiro-Ren Alicia
A Meanwell Nicholas
Liu Zheng
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BR112014006559A2 publication Critical patent/BR112014006559A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112014006559A 2011-09-21 2012-09-20 derivados do ácido betulínico com atividade antiviral BR112014006559A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161537099P 2011-09-21 2011-09-21
PCT/US2012/056186 WO2013043778A1 (en) 2011-09-21 2012-09-20 Novel betulinic acid derivatives with antiviral activity

Publications (1)

Publication Number Publication Date
BR112014006559A2 true BR112014006559A2 (pt) 2017-03-28

Family

ID=46964090

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014006559A BR112014006559A2 (pt) 2011-09-21 2012-09-20 derivados do ácido betulínico com atividade antiviral

Country Status (15)

Country Link
US (1) US8754069B2 (enExample)
EP (1) EP2758419B8 (enExample)
JP (1) JP6100786B2 (enExample)
KR (1) KR20140069167A (enExample)
CN (1) CN103814042B (enExample)
AU (1) AU2012312485B2 (enExample)
BR (1) BR112014006559A2 (enExample)
CA (1) CA2849475A1 (enExample)
EA (1) EA023463B1 (enExample)
ES (1) ES2611727T3 (enExample)
IL (1) IL231421A (enExample)
MX (1) MX2014002936A (enExample)
SG (1) SG11201400331WA (enExample)
TW (1) TW201317255A (enExample)
WO (1) WO2013043778A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906889B2 (en) * 2012-02-15 2014-12-09 Bristol-Myers Squibb Company C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
US8889854B2 (en) 2012-05-07 2014-11-18 Bristol-Myers Squibb Company C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
KR20170135970A (ko) * 2015-04-14 2017-12-08 비브 헬스케어 유케이 (넘버4) 리미티드 Hiv 성숙화 억제제를 생산하는 방법
KR20180028534A (ko) 2015-07-28 2018-03-16 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 Hiv 감염을 예방하거나 치료하기 위한 베투인 유도체
RU2018105352A (ru) 2015-07-28 2019-08-29 ГлаксоСмитКлайн Интеллекчуал Проперти (N2) Лимитед Производные бетулина для предупреждения или лечения ВИЧ-инфекций
CN108368071A (zh) 2015-09-24 2018-08-03 葛兰素史克知识产权第二有限公司 具有hiv成熟抑制活性的化合物
CN108699103A (zh) 2016-01-20 2018-10-23 葛兰素史克知识产权第二有限公司 具有hiv成熟抑制活性的羽扇烷类的胺衍生物
EP3478661A1 (en) * 2016-06-30 2019-05-08 ViiV Healthcare UK (No.5) Limited Aza-substituted inhibitors of human immunodeficiency virus replication
WO2019207460A1 (en) 2018-04-24 2019-10-31 VIIV Healthcare UK (No.5) Limited Compounds with hiv maturation inhibitory activity
NZ769842A (en) * 2018-06-29 2023-01-27 Dfh Therapeutics Triterpene amine derivatives
MX2021009584A (es) * 2019-02-11 2021-09-23 Hetero Labs Ltd Nuevos derivados de triterpeno como inhibidores del virus de la inmunodeficiencia humana (vih).
CN115380040A (zh) * 2020-02-11 2022-11-22 熙德隆制药有限公司 作为hiv抑制剂的新型三萜衍生物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
US5962527A (en) 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
US5869535A (en) 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
US5679828A (en) 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7365221B2 (en) 2002-09-26 2008-04-29 Panacos Pharmaceuticals, Inc. Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
WO2004089357A2 (en) 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil
US7745625B2 (en) 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
JP2007529544A (ja) 2004-03-17 2007-10-25 パナコス ファーマシューティカルズ, インコーポレイテッド 3−o−(3’,3’−ジメチルスクシニル)ベツリン酸の製薬的な塩
TW200628161A (en) * 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
WO2008127364A2 (en) 2006-10-13 2008-10-23 Myriad Genetics, Inc. Antiviral compounds and use thereof
US20110144069A1 (en) 2006-10-16 2011-06-16 Myriad Genetics, Incorporated Compounds for treating viral infections
CA2714049A1 (en) * 2008-02-14 2009-08-20 Virochem Pharma Inc. Novel 17.beta. lupane derivatives
US9067966B2 (en) * 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
ES2612452T3 (es) 2010-06-04 2017-05-17 VIIV Healthcare UK (No.5) Limited Derivados de ácido betulínico C-3 modificados como inhibidores de la maduración del VIH
EP2576586B1 (en) 2010-06-04 2015-08-12 Bristol-Myers Squibb Company C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors
ES2653847T3 (es) 2011-01-31 2018-02-09 Viiv Healthcare Uk (No. 4) Limited Triterpenoides C-17 y C-3 modificados con actividad inhibitoria contra maduración del VIH
CN103339141B (zh) 2011-01-31 2016-08-24 百时美施贵宝公司 作为hiv成熟抑制剂的c-3修饰的桦木酸衍生物的c-28胺

Also Published As

Publication number Publication date
SG11201400331WA (en) 2014-08-28
IL231421A (en) 2015-11-30
KR20140069167A (ko) 2014-06-09
CA2849475A1 (en) 2013-03-28
JP2014526554A (ja) 2014-10-06
US8754069B2 (en) 2014-06-17
AU2012312485B2 (en) 2016-09-01
US20130072465A1 (en) 2013-03-21
EA201490643A1 (ru) 2014-06-30
JP6100786B2 (ja) 2017-03-22
EP2758419B8 (en) 2017-04-19
EP2758419A1 (en) 2014-07-30
MX2014002936A (es) 2014-04-25
AU2012312485A1 (en) 2014-05-08
WO2013043778A1 (en) 2013-03-28
CN103814042A (zh) 2014-05-21
EA023463B1 (ru) 2016-06-30
IL231421A0 (en) 2014-04-30
CN103814042B (zh) 2015-08-19
EP2758419B1 (en) 2016-10-19
ES2611727T3 (es) 2017-05-10
TW201317255A (zh) 2013-05-01

Similar Documents

Publication Publication Date Title
BR112014006559A2 (pt) derivados do ácido betulínico com atividade antiviral
CY1124000T1 (el) Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη
MX2012015097A (es) Derivados de acido naft-2-ilacetico para tratar sida.
MX378354B (es) Mejoramiento de autofagia o incremento de longevidad por administracion de urolitinas o precursores de las mismas.
ECSP13012418A (es) Derivados de ácido 2-quinolin-acético como compuestos antivirales para vih
BR112014010576A2 (pt) inibidores de neprilisina
ECSP13012612A (es) Derivados de quinazolin-4-(3h)-ona utilizados como inhibidores de p13 cinasa
EA201391098A1 (ru) C-28-амины c-3-модифицированных производных бетулиновой кислоты в качестве ингибиторов созревания вич
EA201391127A1 (ru) C-17 и c-3 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
MD4496B1 (ro) Analogi carba-nucleozidici 2'-substituiţi pentru tratament antiviral
MA33939B1 (fr) 5-alcynyl-pyrimidines
UA111770C2 (uk) Інгібітори бромдомену
BR112015018491A2 (pt) triterpenoides c-19-modificados com atividade inibidora de maturação de hiv
BR112015019590A2 (pt) derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv
MX2019003738A (es) Compuestos antivirales.
EA201390198A1 (ru) Гетероциклическое соединение
EA201301154A1 (ru) Разветвленные производные 3-фенилпропионовой кислоты и их применение
BR112015000399A2 (pt) derivados de pirazolil pirimidina
EA201270216A1 (ru) Фармацевтический состав
JO3387B1 (ar) مشتقات بيتولين
BR112015009395A2 (pt) processo para preparação de derivados do ácido biliar
BR112014004219A2 (pt) pirano[3,2-d][1,3]tiazol como inibidores de glicosidase
BR112015002118A2 (pt) 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos
MX2015003021A (es) Derivados de acido glicirretinico y metodos de uso de los mismos.
BR112014019672A8 (pt) Triterpenoides de c-3 cicloalquenila com atividade inibidora de maturação de hiv

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2532 DE 16-07-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.